Welcome to our dedicated page for JIN MED INTL LTD. news (Ticker: ZJYL), a resource for investors and traders seeking the latest updates and insights on JIN MED INTL LTD. stock.
JIN MED INTL LTD (ZJYL) delivers innovative rehabilitation equipment and living aids designed to enhance mobility for individuals with disabilities. This news hub provides investors and healthcare industry professionals with timely updates on the company's operational developments, product innovations, and market strategies.
Access comprehensive coverage of financial results, product launches, and strategic partnerships related to ZJYL's wheelchair series, bathing aids, and respiratory support devices. Our curated news collection serves as an essential resource for tracking the company's progress in medical device manufacturing and international distribution networks.
Key updates include developments in assistive technology R&D, expansion of Japanese market operations, and quality control initiatives within ZJYL's manufacturing processes. All content is verified for accuracy to support informed decision-making about this rehabilitation equipment specialist.
Bookmark this page for centralized access to ZJYL's latest corporate announcements and industry analysis. Check regularly for updates reflecting the company's commitment to advancing mobility solutions through engineered medical devices.
Jin Medical International (NASDAQ: ZJYL) has received a deficiency notice from Nasdaq on May 2, 2025, due to non-compliance with the minimum bid price requirement. The company's stock price remained below $1.00 for 30 consecutive business days between March 20 and May 1, 2025. ZJYL has been granted a 180-day compliance period until October 29, 2025, to regain compliance by maintaining a closing bid price of $1.00 or higher for at least 10 consecutive business days.
If unsuccessful, the company may be eligible for an additional 180-day period, provided it meets other Nasdaq Capital Market listing requirements. Options for compliance include implementing a reverse stock split. Failure to meet requirements could result in delisting from Nasdaq.
JIN MEDICAL INTERNATIONAL (NASDAQ: ZJYL), a leader in Assistive Technologies (AT) and manufacturer of wheelchairs and living aids, has announced the start of construction for its new manufacturing facility in Chuzhou City, Anhui Province, China. The facility, operated by JinMed (Anhui) Co., , will be an internationally standardized, innovative, and high-end wheelchair manufacturing plant.
The new facility is expected to strengthen JinMed's position in the AT industry with higher-level production lines and more innovative products. Targeted to operate in 2025, it will expand capacity for manual wheelchairs and introduce production lines for electric wheelchairs, electric scooters, micro hyperbaric chambers, and scientific cosmetic products.
CEO Wang Erqi stated that this development marks a major milestone for JinMed, aligning with their goal of 'global technology for the benefit of mankind' and demonstrating the company's commitment to industry leadership.
FAQ
What is the current stock price of JIN MED INTL LTD. (ZJYL)?
What is the market cap of JIN MED INTL LTD. (ZJYL)?
